A randomised, placebo controlled, comparative trial of the gastrointestinal safety and efficacy of AZD3582 versus naproxen in osteoarthritis
about
New horizons and perspectives in the treatment of osteoarthritisPeptic ulcer disease todayBuilding a better aspirin: gaseous solutions to a century-old problemNMI-1182, a gastro-protective cyclo-oxygenase-inhibiting nitric oxide donor.Dose-effect comparisons of the CINOD AZD3582 and naproxen on upper gastrointestinal tract mucosal injury in healthy subjects.Lumiracoxib in the management of osteoarthritis and acute pain.Common secondary causes of resistant hypertension and rational for treatmentModelling of pain intensity and informative dropout in a dental pain model after naproxcinod, naproxen and placebo administration.Updated consensus statement on biological agents, specifically tumour necrosis factor {alpha} (TNF{alpha}) blocking agents and interleukin-1 receptor antagonist (IL-1ra), for the treatment of rheumatic diseases, 2005Greater reduction of knee than hip pain in osteoarthritis treated with naproxen, as evaluated by WOMAC and SF-36Treatment strategies for osteoarthritis patients with pain and hypertension.Role of nitric oxide in the gastrointestinal tractChemopreventive efficacy of naproxen and nitric oxide-naproxen in rodent models of colon, urinary bladder, and mammary cancers.Identifying and managing factors that interfere with or worsen blood pressure control.Mechanisms, prevention and clinical implications of nonsteroidal anti-inflammatory drug-enteropathy.Recent developments in chimeric NSAIDs as safer anti-inflammatory agents.Nonsteroidal Anti-Inflammatory Therapy: A Journey Toward Safety.Efficacy and tolerability of naproxen/esomeprazole magnesium tablets compared with non-specific NSAIDs and COX-2 inhibitors: a systematic review and network analyses.Gaseous Mediators in Gastrointestinal Mucosal Defense and Injury.Clinical pharmacokinetics of the cyclooxygenase inhibiting nitric oxide donator (CINOD) AZD3582.Efficacy, safety, and effects on blood pressure of naproxcinod 750 mg twice daily compared with placebo and naproxen 500 mg twice daily in patients with osteoarthritis of the hip: a randomized, double-blind, parallel-group, multicenter study.The dichotomous role of H2S in cancer cell biology? Déjà vu all over again.Naproxcinod, a new cyclooxygenase-inhibiting nitric oxide donator (CINOD)
P2860
Q24657795-5ACDEA36-0CF1-41A4-9B81-21C711C564FDQ28194844-C58700AF-52DD-4285-B5AC-D10E82EBC331Q28218664-C9BFBD99-EAC4-407E-90E6-9D43EABE413CQ34464035-460E2114-7A71-4850-B598-3CD91A6765F6Q34497273-4C383938-4B84-4544-A0DA-2F1BA4363E4DQ34657320-5B0F41E4-5748-4807-8EA6-76911268FA87Q34669789-3B9EBC44-E0C6-47AF-928F-E154D28E25E2Q34996927-6B07CD56-179F-406C-AE0C-209A3645E5A0Q35579517-BEBBE0BC-8B15-4187-B584-0D939772F208Q35637289-E89487F5-405E-4EBB-9D4E-5B85D2FBCA47Q36059512-B6297D49-9E44-478D-AB57-9557F9EA859CQ36972486-9BE3B079-096B-4C61-80F3-A89644E2C1A5Q37415607-50EEFBB3-40F6-42B4-9168-47A4E26E59FEQ37702724-E015165E-7BFC-429B-B44B-C8D4444376BEQ38097424-B2176AEB-7136-4D2C-9B27-F3820B9D3488Q38260626-E7F0BDC5-36B0-4197-B993-022B11607C51Q38558587-CB8017E7-E776-4E67-91FC-5BF95E95B4DBQ38993297-EC3B8C30-C98A-450A-A07E-816D17D17B61Q39451528-1EE507F0-47A7-4143-BD44-EE9661DF8366Q39739399-5B3ACF37-AAD0-47CA-AC60-A9E8D1429F2EQ42932965-C0DC3EB9-AB03-4E26-BB3D-ACFB95CBF07CQ49346285-FABA0F05-3852-441C-8DA4-4CC16C919215Q57480564-862A3DC5-F21F-41AA-A7B8-1BD2BC71D2CF
P2860
A randomised, placebo controlled, comparative trial of the gastrointestinal safety and efficacy of AZD3582 versus naproxen in osteoarthritis
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
A randomised, placebo controll ...... sus naproxen in osteoarthritis
@ast
A randomised, placebo controll ...... sus naproxen in osteoarthritis
@en
type
label
A randomised, placebo controll ...... sus naproxen in osteoarthritis
@ast
A randomised, placebo controll ...... sus naproxen in osteoarthritis
@en
prefLabel
A randomised, placebo controll ...... sus naproxen in osteoarthritis
@ast
A randomised, placebo controll ...... sus naproxen in osteoarthritis
@en
P2093
P2860
P356
P1476
A randomised, placebo controll ...... sus naproxen in osteoarthritis
@en
P2093
J Szechinski
M Malmenäs
O Svensson
STAR Multinational Study Group
P2860
P304
P356
10.1136/ARD.2004.023572
P407
P577
2004-09-02T00:00:00Z